Press release
Schistosomiasis Drugs Market Size, Share, Recent Developments and Forecast 2024-2031 - Merck & Co., Salvensis, Bayer AG.
Schistosomiasis Drugs Market
Will the Schistosomiasis Drugs Market become the sector's next big opportunity? To find out, delve into the analysis and projections for Schistosomiasis Drugs Market. This market research study offers in-depth insights into the opportunities, challenges, and trends currently shaping the machinery landscape, enabling industry participants to make informed decisions in a dynamic environment. Take advantage of the opportunity in the Schistosomiasis Drugs Market! (2031)
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/schistosomiasis-drugs-market
Schistosomiasis Drugs Market was valued at USD 70.4 million in 2021. It is forecasted to reach USD million by 2031, growing at a CAGR of 3.8% during the forecast period (2024-2031).
Key Growth Drivers in Schistosomiasis Drugs Market:
Drugs for schistosomiasis, a parasitic disease caused by trematode worms of the genus Schistosoma, primarily include praziquantel. This medication is effective in treating the infection by targeting the adult worms and causing their paralysis and disintegration. Praziquantel is the most commonly prescribed treatment, particularly in endemic areas where schistosomiasis is prevalent. Research is ongoing to develop additional therapies and improve treatment regimens, especially for drug-resistant strains of the parasite. Effective management of schistosomiasis is crucial for public health, particularly in regions where the disease is endemic.
DataM Intelligence profiles some of the most reputed organizations present in the Schistosomiasis Drugs market. They are as follows:
Chemos GmbH & Co. KG, Shin Poong Pharma. Co. Ltd., Meher Distributors Pvt. Ltd., Merck & Co., Salvensis, Bayer AG, LondonPharma Ltd, Merck & Co., Inc., 3S Corporation Kancera AB, Taj Pharmaceuticals Ltd., Avanscure Lifesciences Pvt. Ltd, CBC Pharma., VHB Life Science Inc., Samarth Pharma Pvt. Ltd., Taj Pharmaceuticals Ltd., and Egyptian International Pharmaceuticals Industries Co SAE.
Segment Covered in the Schistosomiasis Drugs Market:
By Site: Intestinal Schistosomiasis, Urogenital Schistosomiasis.
By Species Type: Schistosoma mansoni, Schistosoma japonicum, Schistosoma mekongi, Schistosoma guineensis, Schistosoma haematobium.
By Drug Type: Praziquantel (Biltricide), Oxamniquine (Vansil), Metrifonate, Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others.
Regional Analysis:
The global Schistosomiasis Drugs Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
Key Developments
In January 2020, Merck, a prominent science and technology company, achieved a significant milestone by donating 1 billion tablets of praziquantel to the World Health Organization (WHO). Praziquantel is the standard medication used to treat schistosomiasis, a neglected tropical disease (NTD) that predominantly affects children in impoverished rural areas. This major contribution is part of Merck's long-standing commitment to combat schistosomiasis, starting in 2007, and has enabled the treatment of approximately 400 million school-aged children in Sub-Saharan Africa. The donation is a key step towards eliminating this debilitating disease, which continues to impact vulnerable populations worldwide.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=schistosomiasis-drugs-market
Regional Analysis:
The global Schistosomiasis Drugs Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Schistosomiasis Drugs Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Points Covered:
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Schistosomiasis Drugs market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Schistosomiasis Drugs Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global Schistosomiasis Drugs market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Schistosomiasis Drugs Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/schistosomiasis-drugs-market
FAQ's
Q.1. What are the primary drivers of the Schistosomiasis Drugs Industry?
Q.2. What are the main factors propelling and impeding the growth of the Schistosomiasis Drugs market?
Q.3. What are the general structure, risks, and opportunities of the market?
Q.4. How do the prices, revenue, and sales of the leading Schistosomiasis Drugs market firms compare?
Q.5. What are the main segments of the market and how is it divided up?
Q.6. Which companies dominate the market, and what percentage of the market do they control?
Q.7. What trends are influencing the Schistosomiasis Drugs market now and in the future?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Schistosomiasis Drugs Market Size, Share, Recent Developments and Forecast 2024-2031 - Merck & Co., Salvensis, Bayer AG. here
News-ID: 3699513 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Orthopedic Power Tools Market to Surpass USD 3 Billion by 2031, Report by DataM …
Overview of the Orthopedic Power Tools Market
The orthopedic power tools market is a vital segment of the broader orthopedic surgical equipment industry, offering a range of powered instruments designed to enhance precision, efficiency, and safety in orthopedic procedures. These tools, which include drills, saws, reamers, and screwdrivers, are essential for tasks such as bone cutting, shaping, and implant placement. The market has witnessed substantial growth due to the escalating prevalence…
Digital X-Ray Market Size to Hit USD 8.3 Billion with 4.4% CAGR by 2033, Report …
Overview of the Digital X-Ray Market
The Digital X-ray Market has witnessed transformative growth, driven by rapid technological advancements and the global push towards digitization in healthcare. Digital X-ray systems leverage digital detectors instead of conventional photographic films to capture medical images electronically, offering faster image acquisition, superior image quality, and simplified storage and transmission capabilities. This shift enables healthcare providers to diagnose and treat a wide variety of conditions,…
In Vitro Fertilization Market to Expand at 9.7% CAGR Through 2031, Says DataM In …
Overview of the In Vitro Fertilization Market
The In Vitro Fertilization (IVF) market represents a key segment of assisted reproductive technology (ART), offering life-changing solutions to millions of couples facing infertility worldwide. IVF involves fertilizing an egg with sperm outside the human body in a controlled laboratory environment and then implanting the embryo into the uterus. This method has revolutionized fertility treatments by providing options for individuals and couples…
AI in Telemedicine Market to Hit USD 193.30 Billion by 2033, Report by DataM Int …
Overview of the AI in Telemedicine Market
The AI in Telemedicine market represents an innovative fusion of artificial intelligence technologies with digital healthcare services, creating a paradigm shift in patient care delivery. By integrating AI algorithms such as machine learning, natural language processing, computer vision, and predictive analytics into telemedicine platforms, healthcare providers can offer enhanced diagnostics, remote patient monitoring, virtual consultations, and personalized treatment regimens. This convergence enables more efficient,…
More Releases for Schistosomiasis
Schistosomiasis Market Share, Epidemiology, Analysis & Trends 2023-2033
Schistosomiasis Market Report Overview:
Report Attribute Details
Base Year 2022
Forecast Years …
Schistosomiasis Pipeline Featuring 3+ Companies Expected to Change the Pace of t …
"The infectious form of the parasite, known as cercariae, emerge from the snail into the water. You can become infected when your skin comes in contact with contaminated freshwater. Most human infections are caused by Schistosoma mansoni, S. haematobium, or S. japonicum"
The drug is described in detail in the Schistosomiasis pipeline report, along with its mechanism of action, Schistosomiasis clinical trials, Schistosomiasis NDA approvals (if any), and product development activities…
Drugs for Schistosomiasis Market - key players covered:EIPICO, Chandra Bhagat Ph …
Los Angeles, United State, –The report titled Global Drugs for Schistosomiasis Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Drugs for Schistosomiasis market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of…
Schistosomiasis Therapeutics- Pipeline Analysis 2018
Schistosomiasis is an acute and chronic disease caused by parasitic worms of the genus Schistosoma, during routine domestic, occupational, agricultural, and recreational activities, which involves infested water exposure.
Download the sample report @ https://www.pharmaproff.com/request-sample/1070
School children are more prone to schistosomiasis due to lack of hygiene and certain play habits, such as swimming or fishing in infested water. Symptoms of schistosomiasis are caused by the body’s reaction to the worms' eggs.…
Schistosomiasis-Pipeline Review H2 2018
Schistosomiasis is a type of infection caused by parasites that live in fresh water, such as rivers or lakes. Symptoms include a high temperature, headache, cough, a dark red, blotchy, raised skin rash, pain in the abdomen and joint and muscle pain.
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Schistosomiasis-Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Schistosomiasis (Infectious Disease), complete with analysis by…
Schistosomiasis Treatment Market Size, Outlook, and Opportunity Analysis, 2018-2 …
Schistosomiasis is a disease caused by infection with freshwater parasitic worms. It can be acute or chronic infection mainly caused by parasitic worm’s blood flukes (trematode worms). There are two forms of schistosomiasis, such as intestinal and urogenital. According to the World Health Organization (WHO) reports in 2017, urogenital schistosomiasis is a high risk factor for the transmission of HIV infection in women. People usually get infected during agriculture, domestic,…
